Revise to specify the comparative strength of evidence for oral vs. topical formulations.
Background
Skin aging is a significant concern for many individuals, impacting both appearance and self-esteem. Peptide-based therapies have gained attention for their potential to improve various signs of skin aging, such as wrinkles and dryness. Understanding the efficacy and safety of these treatments is crucial for dermatologists and healthcare providers in recommending appropriate interventions.
Data Highlights
Adjust the evidence strength for skin brightness and roughness to align with the source.
Key Findings
Peptide therapies showed statistically significant improvements in skin hydration and wrinkle appearance compared to placebo.
Oral peptide formulations contributed significantly to observed benefits, particularly for hydration and wrinkle reduction.
Topical peptide therapies had limited evidence due to a small number of studies.
Peptides may stimulate collagen production and support skin structure through various mechanisms.
Peptide therapies were generally well tolerated, with mild gastrointestinal discomfort noted in some cases.
Standardized research is needed to confirm findings and improve comparability across studies.
Clinical Implications
Peptide-based therapies may serve as a noninvasive adjunct in aesthetic dermatology, particularly for improving hydration and overall skin appearance. Clinicians should consider the stronger evidence supporting oral formulations while remaining cautious about the modest benefits and variability across studies.
Conclusion
Strengthen the conclusion by reiterating the need for further research to confirm findings.
Media portrayals of forensic skin evidence create unrealistic jury expectations—and dermatologists testifying in court may need strategies to address them
